CanadaBis Capital Inc (V:CANB) — Market Cap & Net Worth
Market Cap & Net Worth: CanadaBis Capital Inc (CANB)
CanadaBis Capital Inc (V:CANB) has a market capitalization of $1.53 Million (CA$2.12 Million) as of September 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #30357 globally and #1525 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CanadaBis Capital Inc's stock price CA$0.02 by its total outstanding shares 141022815 (141.02 Million). Also see CanadaBis Capital Inc total assets for a full breakdown of the balance sheet.
CanadaBis Capital Inc Market Cap History: 2017 to 2026
CanadaBis Capital Inc's market capitalization history from 2017 to 2026. Data shows change from $29.58 Million to $1.53 Million (-27.22% CAGR). Also see cash flow conversion of CanadaBis Capital Inc for how efficiently the company converts equity into cash flow.
CanadaBis Capital Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CanadaBis Capital Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CANB live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.18x
CanadaBis Capital Inc's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $10.20 Million | $4.43 Million | -$5.39 Million | 2.30x | N/A |
| 2021 | $4.59 Million | $6.87 Million | -$2.68 Million | 0.67x | N/A |
| 2022 | $8.16 Million | $11.67 Million | $608.33K | 0.70x | 13.42x |
| 2023 | $26.01 Million | $22.22 Million | $4.44 Million | 1.17x | 5.85x |
| 2024 | $5.61 Million | $17.95 Million | -$84.06K | 0.31x | N/A |
| 2025 | $3.06 Million | $16.90 Million | -$835.20K | 0.18x | N/A |
Competitor Companies of CANB by Market Capitalization
Companies near CanadaBis Capital Inc in the global market cap rankings as of September 17, 2026. Review CANB tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to CanadaBis Capital Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
CanadaBis Capital Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, CanadaBis Capital Inc's market cap moved from $29.58 Million to $ 1.53 Million, with a yearly change of -27.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.53 Million | -50.00% |
| 2025 | CA$3.06 Million | -45.45% |
| 2024 | CA$5.61 Million | -78.43% |
| 2023 | CA$26.01 Million | +218.75% |
| 2022 | CA$8.16 Million | +77.78% |
| 2021 | CA$4.59 Million | -55.00% |
| 2020 | CA$10.20 Million | -37.50% |
| 2019 | CA$16.32 Million | -55.56% |
| 2018 | CA$36.72 Million | +24.14% |
| 2017 | CA$29.58 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of CanadaBis Capital Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.53 Million USD |
| MoneyControl | $1.53 Million USD |
| MarketWatch | $1.53 Million USD |
| marketcap.company | $1.53 Million USD |
| Reuters | $1.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CanadaBis Capital Inc
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products th… Read more